Glancy Binkow & Goldberg LLP announces that it is investigating potential claims against the board of directors of Arch Chemicals, Inc. (“Arch Chemicals” or the “Company”) (NYSE:ARJ) related to the Company’s agreement to be acquired by Lonza Ltd. in a proposed transaction where Arch Chemicals shareholders will receive $47.20 per share in cash for each share they own of the Company’s common stock. The transaction is valued at approximately $1.2 billion.

The investigation concerns whether the board of directors of Arch Chemicals breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into the proposed transaction, and whether the Company has disclosed all material information to shareholders about the transaction. Arch Chemicals has experienced recent positive financial results. Additionally, at least one analyst has set a target price of $47.00 per share, virtually nullifying any premium that Arch Chemicals shareholders would receive under the transaction.

If you are a shareholder of Arch Chemicals, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Louis Boyarsky, Esquire, Glancy Binkow & Goldberg LLP, 1801 Avenue of the Stars, Suite 311, Los Angeles, CA 90067, by telephone at (310) 201-9150 or Toll Free at (888) 773-9224 or by email to shareholders@glancylaw.com.

Grafico Azioni Arch Chemicals (NYSE:ARJ)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Arch Chemicals
Grafico Azioni Arch Chemicals (NYSE:ARJ)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Arch Chemicals